Literature DB >> 8683101

Protective antibodies in murine Lyme disease arise independently of CD40 ligand.

E Fikrig1, S W Barthold, M Chen, I S Grewal, J Craft, R A Flavell.   

Abstract

Borrelia burgdorferi-infected mice develop acute arthritis that undergoes Ab-mediated resolution. To further investigate the role of B. burgdorferi-specific Abs in Lyme borreliosis, CD40 ligand-deficient (CD40L-deficient) mice were infected with B. burgdorferi. The development and regression of arthritis were similar in CD40L-deficient and control mice. Although CD40L-deficient mice have defects in Ig class switching, infected CD40L-deficient mice developed B. burgdorferi-specific IgG2b Abs. Moreover, the transfer of serum from B. burgdorferi-infected CD40L-deficient animals prevented infection in severe combined immunodeficient mice. These data show that B. burgdorferi-infected CD40L-deficient mice are capable of producing Abs that are protective, despite the inability of these mice to mediate T-dependent immune responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683101

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

Authors:  Y i Hwang; M H Nahm; D E Briles; D Thomas; J M Purkerson
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  BB0238, a presumed tetratricopeptide repeat-containing protein, is required during Borrelia burgdorferi mammalian infection.

Authors:  Ashley M Groshong; Danielle E Fortune; Brendan P Moore; Horace J Spencer; Robert A Skinner; William T Bellamy; Jon S Blevins
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

3.  Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.

Authors:  B K DuChateau; J R Jensen; D M England; S M Callister; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis.

Authors:  V Thomas; J Anguita; S W Barthold; E Fikrig
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice.

Authors:  N Zeidner; M L Mbow; M Dolan; R Massung; E Baca; J Piesman
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.

Authors:  D Chaussabel; F Jacobs; J de Jonge; M de Veerman; Y Carlier; K Thielemans; M Goldman; B Vray
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.

Authors:  M L Mbow; N Zeidner; R D Gilmore; M Dolan; J Piesman; R G Titus
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  E and P selectins are not required for resistance to severe murine lyme arthritis.

Authors:  K P Seiler; Y Ma; J H Weis; P S Frenette; R O Hynes; D D Wagner; J J Weis
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.

Authors:  M J Mathiesen; A Holm; M Christiansen; J Blom; K Hansen; S Ostergaard; M Theisen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Leukocyte transfusion-associated granulocyte responses in a patient with X-linked hyper-IgM syndrome.

Authors:  T P Atkinson; C A Smith; Y M Hsu; E Garber; L Su; T H Howard; J T Prchal; M P Everson; M D Cooper
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.